Annual CFO
$454.60M$79.66M+21.25%
Summary
- Current Value
- As of today, BIO annual cash from operations is $454.60M, up +21.25% on
- Historical Performance
- BIO annual cash from operations is up +209.43% over the past 3 years, and down -0.72% over the past 5 years
- All-Time High Comparison
- BIO annual cash from operations is currently -68.34% below its historical high of $1.44B set on
- 3-Year Low Comparison
- BIO annual cash from operations is +21.25% above its 3-year low of $374.94M reached on
- Sector Comparison
- BIO annual cash from operations is higher than 91.77% of companies in Healthcare sector
Cash From Operations Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Operations | $454.60M | +21.3% | +209.4% | -0.7% | +39.9% | |
| Quarterly Cash From Operations | $120.90M | -26.1% | +109.0% | +155.7% | +80.8% | |
| TTM Cash From Operations | $491.47M | +19.4% | +161.5% | +244.7% | +103.7% | |
| Price | $324.09 | -5.8% | -22.6% | -48.5% | +208.4% | |
| Annual Cash From Investing | -$160.20M | -892.8% | +79.9% | +23.3% | +8.9% | |
| Annual Cash From Financing | -$218.20M | +48.7% | -293.7% | -858.8% | -174.2% | |
| Annual Free Cash Flow | $289.00M | +32.4% | +152.6% | -19.6% | +16.2% | |
| Annual CAPEX | $165.60M | +5.7% | +23.8% | +68.1% | +116.9% | |
| Annual Net Income | -$1.84B | -189.4% | -143.3% | -204.9% | -1336.3% |
Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.44B | N/A | -68.3% |
| 5Y | $1.44B | -68.3% | |
| All | $1.44B | -68.3% |
Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $374.94M | +21.3% | |
| 5Y | -$415.44M | +209.4% | |
| All | -$415.44M | +209.4% |
Cash From Operations History
FAQ
What is the current annual cash from operations of BIO?
As of today, BIO annual cash from operations is $454.60M
What is 1-year change in BIO annual cash from operations?
BIO annual cash from operations is up +21.25% year-over-year
What is 3-year change in BIO annual cash from operations?
BIO annual cash from operations is up +209.43% over the past 3 years
How far is BIO annual cash from operations from its all-time high?
BIO annual cash from operations is currently -68.34% below its historical high of $1.44B set on December 31, 2022
How does BIO annual cash from operations rank versus sector peers?
BIO annual cash from operations is higher than 91.77% of companies in Healthcare sector
When is BIO next annual earnings release?
The next annual earnings release for BIO is on
Quarterly CFO
$120.90M$4.40M+3.78%
Summary
- Current Value
- As of today, BIO quarterly cash from operations is $120.90M, up +3.78% on
- Historical Performance
- BIO quarterly cash from operations is down -26.10% year-over-year, and up +108.95% over the past 3 years
- All-Time High Comparison
- BIO quarterly cash from operations is currently -90.85% below its historical high of $1.32B set on
- 3-Year Low Comparison
- BIO quarterly cash from operations is +141.13% above its 3-year low of -$293.92M reached on
- Sector Comparison
- BIO quarterly cash from operations is higher than 90.54% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Operations | $120.90M | +3.8% | -26.1% | +109.0% | +155.7% | |
| Annual Cash From Operations | $454.60M | – | +21.3% | +209.4% | -0.7% | |
| TTM Cash From Operations | $491.47M | -8.0% | +19.4% | +161.5% | +244.7% | |
| Price | $324.09 | +9.3% | -5.8% | -22.6% | -48.5% | |
| Quarterly Cash From Investing | -$43.00M | +62.7% | +22.7% | +51.4% | -147.3% | |
| Quarterly Cash From Financing | -$52.50M | +61.5% | +45.3% | -498.5% | -10000.0% | |
| Quarterly Free Cash Flow | $89.20M | +26.0% | -27.7% | +106.5% | +137.6% | |
| Quarterly CAPEX | $31.70M | -30.6% | -21.2% | +15.0% | +58.7% | |
| Quarterly Net Income | -$341.90M | -207.6% | -152.3% | -110.0% | -126.0% |
Quarterly Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $129.90M | -6.9% | |
| 3Y | $1.32B | N/A | -90.8% |
| 5Y | $1.32B | -90.8% | |
| All | $1.32B | -90.8% |
Quarterly Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $116.50M | +3.8% | |
| 3Y | -$293.92M | +141.1% | |
| 5Y | -$1.35B | +109.0% | |
| All | -$1.35B | +109.0% |
Quarterly Cash From Operations History
FAQ
What is the current quarterly cash from operations of BIO?
As of today, BIO quarterly cash from operations is $120.90M
What is BIO quarterly cash from operations most recent change?
BIO quarterly cash from operations was up +3.78% on September 30, 2025
What is 1-year change in BIO quarterly cash from operations?
BIO quarterly cash from operations is down -26.10% year-over-year
How far is BIO quarterly cash from operations from its all-time high?
BIO quarterly cash from operations is currently -90.85% below its historical high of $1.32B set on December 31, 2022
How does BIO quarterly cash from operations rank versus sector peers?
BIO quarterly cash from operations is higher than 90.54% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
TTM CFO
$491.47M$42.71M-8.00%
Summary
- Current Value
- As of today, BIO TTM cash from operations is $491.47M, down -8.00% on
- Historical Performance
- BIO TTM cash from operations is up +19.44% year-over-year, and up +161.49% over the past 3 years
- All-Time High Comparison
- BIO TTM cash from operations is currently -69.57% below its historical high of $1.62B set on
- 3-Year Low Comparison
- BIO TTM cash from operations is +1167.32% above its 3-year low of -$46.05M reached on
- Sector Comparison
- BIO TTM cash from operations is higher than 91.45% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Operations | $491.47M | -8.0% | +19.4% | +161.5% | +244.7% | |
| Annual Cash From Operations | $454.60M | – | +21.3% | +209.4% | -0.7% | |
| Quarterly Cash From Operations | $120.90M | +3.8% | -26.1% | +109.0% | +155.7% | |
| Price | $324.09 | +9.3% | -5.8% | -22.6% | -48.5% | |
| TTM Cash From Investing | -$186.04M | +6.4% | -223.8% | +89.2% | -160.8% | |
| TTM Cash From Financing | -$312.77M | +12.2% | +20.3% | -129.4% | -195.2% | |
| TTM Free Cash Flow | $336.76M | -9.2% | +36.6% | +136.1% | +180.0% | |
| TTM CAPEX | $154.71M | -5.2% | -6.2% | +15.3% | +90.1% | |
| TTM Net Income | -$675.90M | -311.8% | +13.2% | +88.8% | -119.2% |
TTM Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $534.18M | -8.0% | |
| 3Y | $1.62B | -69.6% | |
| 5Y | $1.62B | -69.6% | |
| All | $1.62B | -69.6% |
TTM Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $454.60M | N/A | +8.1% |
| 3Y | -$46.05M | +1167.3% | |
| 5Y | -$799.24M | +161.5% | |
| All | -$799.24M | +161.5% |
TTM Cash From Operations History
FAQ
What is the current TTM cash from operations of BIO?
As of today, BIO TTM cash from operations is $491.47M
What is BIO TTM cash from operations most recent change?
BIO TTM cash from operations was down -8.00% on September 30, 2025
What is 1-year change in BIO TTM cash from operations?
BIO TTM cash from operations is up +19.44% year-over-year
How far is BIO TTM cash from operations from its all-time high?
BIO TTM cash from operations is currently -69.57% below its historical high of $1.62B set on September 30, 2023
How does BIO TTM cash from operations rank versus sector peers?
BIO TTM cash from operations is higher than 91.45% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
Cash From Operations Formula
CFO = + Non Cash Expenses + Changes In
Data Sources & References
- BIO Official Website www.bio-rad.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/12208/000001220825000077/0000012208-25-000077-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/12208/000001220825000007/0000012208-25-000007-index.htm
- BIO Profile on Yahoo Finance finance.yahoo.com/quote/BIO
- BIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bio